EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017

EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017

1 Insulin Glargine Overview

1.1 Product Overview and Scope of Insulin Glargine

1.2 Classification of Insulin Glargine

1.2.1 EMEA Insulin Glargine Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Insulin Glargine Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Single Dose Vial

1.2.4 Pre-filled Syringe

1.3 EMEA Insulin Glargine Market by Application/End Users

1.3.1 EMEA Insulin Glargine Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Treat Type 1 Diabetes

1.3.3 Treat Type 2 Diabetes

1.4 EMEA Insulin Glargine Market by Region

1.4.1 EMEA Insulin Glargine Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Insulin Glargine (2012-2022)

1.5.1 EMEA Insulin Glargine Sales and Growth Rate (2012-2022)

1.5.2 EMEA Insulin Glargine Revenue and Growth Rate (2012-2022)

2 EMEA Insulin Glargine Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Insulin Glargine Market Competition by Players/Manufacturers

2.1.1 EMEA Insulin Glargine Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Insulin Glargine Revenue and Share by Players (2012-2017)

2.1.3 EMEA Insulin Glargine Sale Price by Players (2012-2017)

2.2 EMEA Insulin Glargine (Volume and Value) by Type/Product Category

2.2.1 EMEA Insulin Glargine Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Insulin Glargine Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Insulin Glargine Sale Price by Type (2012-2017)

2.3 EMEA Insulin Glargine (Volume) by Application

2.4 EMEA Insulin Glargine (Volume and Value) by Region

2.4.1 EMEA Insulin Glargine Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Insulin Glargine Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Insulin Glargine Sales Price by Region (2012-2017)

3 Europe Insulin Glargine (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Insulin Glargine Sales and Value (2012-2017)

3.1.1 Europe Insulin Glargine Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Insulin Glargine Revenue and Growth Rate (2012-2017)

3.2 Europe Insulin Glargine Sales and Market Share by Type

3.3 Europe Insulin Glargine Sales and Market Share by Application

3.4 Europe Insulin Glargine Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Insulin Glargine Sales Volume by Countries (2012-2017)

3.4.2 Europe Insulin Glargine Revenue by Countries (2012-2017)

3.4.3 Germany Insulin Glargine Sales and Growth Rate (2012-2017)

3.4.4 France Insulin Glargine Sales and Growth Rate (2012-2017)

3.4.5 UK Insulin Glargine Sales and Growth Rate (2012-2017)

3.4.6 Russia Insulin Glargine Sales and Growth Rate (2012-2017)

3.4.7 Italy Insulin Glargine Sales and Growth Rate (2012-2017)

3.4.8 Benelux Insulin Glargine Sales and Growth Rate (2012-2017)

4 Middle East Insulin Glargine (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Insulin Glargine Sales and Value (2012-2017)

4.1.1 Middle East Insulin Glargine Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Insulin Glargine Revenue and Growth Rate (2012-2017)

4.2 Middle East Insulin Glargine Sales and Market Share by Type

4.3 Middle East Insulin Glargine Sales and Market Share by Application

4.4 Middle East Insulin Glargine Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Insulin Glargine Sales Volume by Countries (2012-2017)

4.4.2 Middle East Insulin Glargine Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Insulin Glargine Sales and Growth Rate (2012-2017)

4.4.4 Israel Insulin Glargine Sales and Growth Rate (2012-2017)

4.4.5 UAE Insulin Glargine Sales and Growth Rate (2012-2017)

4.4.6 Iran Insulin Glargine Sales and Growth Rate (2012-2017)

5 Africa Insulin Glargine (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Insulin Glargine Sales and Value (2012-2017)

5.1.1 Africa Insulin Glargine Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Insulin Glargine Revenue and Growth Rate (2012-2017)

5.2 Africa Insulin Glargine Sales and Market Share by Type

5.3 Africa Insulin Glargine Sales and Market Share by Application

5.4 Africa Insulin Glargine Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Insulin Glargine Sales Volume by Countries (2012-2017)

5.4.2 Africa Insulin Glargine Revenue by Countries (2012-2017)

5.4.3 South Africa Insulin Glargine Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Insulin Glargine Sales and Growth Rate (2012-2017)

5.4.5 Egypt Insulin Glargine Sales and Growth Rate (2012-2017)

5.4.6 Algeria Insulin Glargine Sales and Growth Rate (2012-2017)

6 EMEA Insulin Glargine Manufacturers/Players Profiles and Sales Data

6.1 Sanofi-Aventis

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Insulin Glargine Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Ganlee

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Insulin Glargine Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Biocon

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Insulin Glargine Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

...

7 Insulin Glargine Manufacturing Cost Analysis

7.1 Insulin Glargine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Insulin Glargine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Insulin Glargine Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Insulin Glargine Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Insulin Glargine Market Forecast (2017-2022)

11.1 EMEA Insulin Glargine Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Insulin Glargine Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Insulin Glargine Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Insulin Glargine Price and Trend Forecast (2017-2022)

11.2 EMEA Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Insulin Glargine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Insulin Glargine Sales Forecast by Type (2017-2022)

11.7 EMEA Insulin Glargine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Insulin Glargine

Figure EMEA Insulin Glargine Sales Volume (M ml) by Type (2012-2022)

Figure EMEA Insulin Glargine Sales Volume Market Share by Type (Product Category) in 2016

Figure Single Dose Vial Product Picture

Figure Pre-filled Syringe Product Picture

Figure EMEA Insulin Glargine Sales Volume (M ml) by Application (2012-2022)

Figure EMEA Sales Market Share of Insulin Glargine by Application in 2016

Figure Treat Type 1 Diabetes Examples

Figure Treat Type 2 Diabetes Examples

Figure EMEA Insulin Glargine Market Size (Million USD) by Region (2012-2022)

Figure Europe Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Insulin Glargine Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Insulin Glargine Revenue (Million USD) Status and Forecast by Countries

Figure Africa Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Insulin Glargine Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Insulin Glargine Sales Volume and Growth Rate (2012-2022)

Figure EMEA Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Insulin Glargine Market Major Players Product Sales Volume (M ml) (2012-2017)

Table EMEA Insulin Glargine Sales Volume (M ml) of Major Players (2012-2017)

Table EMEA Insulin Glargine Sales Share by Players (2012-2017)

Figure 2016 Insulin Glargine Sales Share by Players

Figure 2017 Insulin Glargine Sales Share by Players

Figure EMEA Insulin Glargine Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Insulin Glargine Revenue (Million USD) by Players (2012-2017)

Table EMEA Insulin Glargine Revenue Share by Players (2012-2017)

Table 2016 EMEA Insulin Glargine Revenue Share by Players

Table 2017 EMEA Insulin Glargine Revenue Share by Players

Table EMEA Insulin Glargine Sale Price (USD/ml) by Players (2012-2017)

Table EMEA Insulin Glargine Sales (M ml) and Market Share by Type (2012-2017)

Table EMEA Insulin Glargine Sales Share by Type (2012-2017)

Figure Sales Market Share of Insulin Glargine by Type (2012-2017)

Figure EMEA Insulin Glargine Sales Market Share by Type (2012-2017)

Table EMEA Insulin Glargine Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Insulin Glargine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Insulin Glargine by Type in 2016

Table EMEA Insulin Glargine Sale Price (USD/ml) by Type (2012-2017)

Table EMEA Insulin Glargine Sales (M ml) and Market Share by Application (2012-2017)

Table EMEA Insulin Glargine Sales Share by Application (2012-2017)

Figure Sales Market Share of Insulin Glargine by Application (2012-2017)

Figure EMEA Insulin Glargine Sales Market Share by Application in 2016

Table EMEA Insulin Glargine Sales (M ml) and Market Share by Region (2012-2017)

Table EMEA Insulin Glargine Sales Share by Region (2012-2017)

Figure Sales Market Share of Insulin Glargine by Region (2012-2017)

Figure EMEA Insulin Glargine Sales Market Share in 2016

Table EMEA Insulin Glargine Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Insulin Glargine Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Insulin Glargine by Region (2012-2017)

Figure EMEA Insulin Glargine Revenue Market Share Regions in 2016

Table EMEA Insulin Glargine Sales Price (USD/ml) by Region (2012-2017)

Figure Europe Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Europe Insulin Glargine Revenue and Growth Rate (2012-2017)

Table Europe Insulin Glargine Sales (M ml) by Type (2012-2017)

Table Europe Insulin Glargine Market Share by Type (2012-2017)

Figure Europe Insulin Glargine Market Share by Type in 2016

Table Europe Insulin Glargine Sales (M ml) by Application (2012-2017)

Table Europe Insulin Glargine Market Share by Application (2012-2017)

Figure Europe Insulin Glargine Market Share by Application in 2016

Table Europe Insulin Glargine Sales (M ml) by Countries (2012-2017)

Table Europe Insulin Glargine Sales Market Share by Countries (2012-2017)

Figure Europe Insulin Glargine Sales Market Share by Countries (2012-2017)

Figure Europe Insulin Glargine Sales Market Share by Countries in 2016

Table Europe Insulin Glargine Revenue (Million USD) by Countries (2012-2017)

Table Europe Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Europe Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Europe Insulin Glargine Revenue Market Share by Countries in 2016

Figure Germany Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure France Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure UK Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Russia Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Italy Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Benelux Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Middle East Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Middle East Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Insulin Glargine Sales (M ml) by Type (2012-2017)

Table Middle East Insulin Glargine Market Share by Type (2012-2017)

Figure Middle East Insulin Glargine Market Share by Type (2012-2017)

Table Middle East Insulin Glargine Sales (M ml) by Applications (2012-2017)

Table Middle East Insulin Glargine Market Share by Applications (2012-2017)

Figure Middle East Insulin Glargine Sales Market Share by Application in 2016

Table Middle East Insulin Glargine Sales Volume (M ml) by Countries (2012-2017)

Table Middle East Insulin Glargine Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Insulin Glargine Sales Volume Market Share by Countries in 2016

Table Middle East Insulin Glargine Revenue (Million USD) by Countries (2012-2017)

Table Middle East Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Middle East Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Middle East Insulin Glargine Revenue Market Share by Countries in 2016

Figure Saudi Arabia Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Israel Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure UAE Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Iran Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Africa Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Africa Insulin Glargine Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Insulin Glargine Sales (M ml) by Type (2012-2017)

Table Africa Insulin Glargine Sales Market Share by Type (2012-2017)

Figure Africa Insulin Glargine Sales Market Share by Type (2012-2017)

Figure Africa Insulin Glargine Sales Market Share by Type in 2016

Table Africa Insulin Glargine Sales (M ml) by Application (2012-2017)

Table Africa Insulin Glargine Sales Market Share by Application (2012-2017)

Figure Africa Insulin Glargine Sales Market Share by Application (2012-2017)

Table Africa Insulin Glargine Sales Volume (M ml) by Countries (2012-2017)

Table Africa Insulin Glargine Sales Market Share by Countries (2012-2017)

Figure Africa Insulin Glargine Sales Market Share by Countries (2012-2017)

Figure Africa Insulin Glargine Sales Market Share by Countries in 2016

Table Africa Insulin Glargine Revenue (Million USD) by Countries (2012-2017)

Table Africa Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Africa Insulin Glargine Revenue Market Share by Countries (2012-2017)

Figure Africa Insulin Glargine Revenue Market Share by Countries in 2016

Figure South Africa Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Nigeria Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Egypt Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Algeria Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Table Sanofi-Aventis Insulin Glargine Basic Information List

Table Sanofi-Aventis Insulin Glargine Sales (M ml), Revenue (Million USD), Price (USD/ml) and Gross Margin (2012-2017)

Figure Sanofi-Aventis Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Sanofi-Aventis Insulin Glargine Sales Market Share in EMEA (2012-2017)

Figure Sanofi-Aventis Insulin Glargine Revenue Market Share in EMEA (2012-2017)

Table Ganlee Insulin Glargine Basic Information List

Table Ganlee Insulin Glargine Sales (M ml), Revenue (Million USD), Price (USD/ml) and Gross Margin (2012-2017)

Figure Ganlee Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Ganlee Insulin Glargine Sales Market Share in EMEA (2012-2017)

Figure Ganlee Insulin Glargine Revenue Market Share in EMEA (2012-2017)

Table Biocon Insulin Glargine Basic Information List

Table Biocon Insulin Glargine Sales (M ml), Revenue (Million USD), Price (USD/ml) and Gross Margin (2012-2017)

Figure Biocon Insulin Glargine Sales (M ml) and Growth Rate (2012-2017)

Figure Biocon Insulin Glargine Sales Market Share in EMEA (2012-2017)

Figure Biocon Insulin Glargine Revenue Market Share in EMEA (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Insulin Glargine

Figure Manufacturing Process Analysis of Insulin Glargine

Figure Insulin Glargine Industrial Chain Analysis

Table Raw Materials Sources of Insulin Glargine Major Manufacturers in 2016

Table Major Buyers of Insulin Glargine

Table Distributors/Traders List

Figure EMEA Insulin Glargine Sales (M ml) and Growth Rate Forecast (2017-2022)

Figure EMEA Insulin Glargine Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Insulin Glargine Price (USD/ml) and Trend Forecast (2017-2022)

Table EMEA Insulin Glargine Sales (M ml) Forecast by Region (2017-2022)

Figure EMEA Insulin Glargine Sales Market Share Forecast by Region (2017-2022)

Table EMEA Insulin Glargine Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Insulin Glargine Revenue Market Share Forecast by Region (2017-2022)

Table Europe Insulin Glargine Sales (M ml) Forecast by Countries (2017-2022)

Figure Europe Insulin Glargine Sales Market Share Forecast by Countries (2017-2022)

Table Europe Insulin Glargine Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Insulin Glargine Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Insulin Glargine Sales (M ml) Forecast by Countries (2017-2022)

Figure Middle East Insulin Glargine Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Insulin Glargine Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Insulin Glargine Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Insulin Glargine Sales (M ml) Forecast by Countries (2017-2022)

Figure Africa Insulin Glargine Sales Market Share Forecast by Countries (2017-2022)

Table Africa Insulin Glargine Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Insulin Glargine Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Insulin Glargine Sales (M ml) Forecast by Type (2017-2022)

Figure EMEA Insulin Glargine Sales Market Share Forecast by Type (2017-2022)

Table EMEA Insulin Glargine Sales (M ml) Forecast by Application (2017-2022)

Figure EMEA Insulin Glargine Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources